New SpaceX Price Target as We Add it to the Portfolio
Meanwhile, we’re exiting this name completely and adding to four other holdings.
You've reached your free article limit
You've read 0 of 1 free Pro articles.
| Symbol | Transaction Type | # Shares Traded | Recent Price $ | Shares Owned After Trade | % Portfolio |
|---|---|---|---|---|---|
| BA | Sell | 500 | 174.25 | 0 | 0.0 |
| AMAT | Buy | 15 | 387.00 | 560 | 3.7 |
| AXON | Buy | 70 | 313.70 | 605 | 3.3 |
| MRVL | Buy | 20 | 166.11 | 1,210 | 3.5 |
| NVDA | Buy | 100 | 172.54 | 1,070 | 3.2 |
| SPCX | Buy | 605 | 140.27 | 605 | 1.5 |
After you receive this alert, the Portfolio will make the following trades:
Sell the remaining 500 shares of Boeing (BA) at or near $173. This will close out the Portfolio’s BA position, with a loss near 15%.
Buy 15 shares of Applied Materials (AMAT) at or near $387. Following the trade, the Portfolio will own 560 AMAT shares, roughly 3.8% of its assets.
Buy 70 shares of Axon (AXON) at or near $312. Following the trade, the Portfolio will own 605 AXON shares, roughly 3.3% of its assets.
Buy 20 shares of Marvell (MRVL) at or near $165. Following the trade, the Portfolio will own 1,210 MRVL shares, roughly 3.5% of its assets.
Buy 100 shares of Nvidia (NVDA) at or near $173. Following the trade, the Portfolio will own 1,070 NVDA shares, roughly 3.25% of its assets.
Buy 605 shares of SpaceX (SPCX) at or near $141. Following the trade, the Portfolio will own 605 SPCX shares, roughly 1.5% of its assets.
Following the supportive data points discussed in our opening comments on Wednesday surrounding CoreWeave (CRWV) and Anthropic, we are concluding our exit of Boeing shares and putting that capital to work in a few existing positions with far better growth prospects as the market moves closer to finding its footing.
We are also initiating a position in SpaceX, using the demand for Anthropic’s IPO offering to do so.
That demand for Anthropic shares builds on what we saw with the recent offerings from Microsoft (MSFT) and Meta (META) that were meaningfully oversubscribed. Not only should that remove some of the overhang on the AI an AI infrastructure with other figures from OpenAI helping reaffirm AI adoption and expanding usage, but it should help address questions over Anthropic’s multi-year spending commitments.
Included among that is the aggregate $120.5 billion it will spend with SpaceX through 2029, which equates to $3.1 billion per month for compute. That compute capacity for just Anthropic is expected to be in place by the end of this year, which means SpaceX’s Super Intelligence business will go through a strong revenue ramp in 2027 compared to the $10.9 billion it did in the first nine months of 2026. That in turn should lift profits at the Super Intelligence segment and reaffirm EPS growth prospects for 2027 and 2028 at the company. It also has the potential for folks to move from wondering why the company is called SpaceX when today the largest profit generator is the Connectivity (Starlink) segment. By next year, the question is likely to be why the company isn’t called the Super Intelligence company, but we’ll leave you to ponder that alongside Elon Musk.
That’s not to say that there won’t be any bumps in the road with SPCX shares. In addition to the colorful personality that is Musk, there are some large lockup periods ahead, the move to compete with wireless service providers and the question over a merger with Tesla (TSLA). We’ll take those one at a time, and subject to ensuing and related developments, revisit the role of SPCX shares in the Portfolio as needed.
As we initiate this position, we will set our initial price target at $200, which gives us ample room to rate it a One. Because this is a new position and the shares can be volatile, we’ll set an initial checkpoint at $120. We’ll have more on SPCX shares in a followup note.
On the housekeeping front, given these moves in several existing positions, we are resetting our checkpoints as follows:
AMAT to $350
AXON to $275
MRVL to $150
NVDA to $155
More Pro Portfolio
- Taking a Healthcare Winner Off the Board
- Tracking 40 Portfolio Signals Across 10 of Our Strategies
- Weekly Roundup: Riding Out the Blue Wave Whiplash With Cash and a Shopping List
(Please note that we are looking to execute these trades at or near the share price mentioned above. Once the trade is completed, subscribers can see the trade’s executed price here. Be sure to toggle the chart to sort by Purchase Date.)
At the time of publication, TheStreet Pro Portfolio was long AMAT, AXON, BA, META, MRVL, MSFT and NVDA shares.
